The Cutaneous Spectrum of Lupus Erythematosus

被引:0
作者
Simone Ribero
Savino Sciascia
Luca Borradori
Dan Lipsker
机构
[1] University of Turin,Department of Medical Sciences, Section of Dermatology
[2] University of Turin,Center of Research of Immunopathology and Rare Diseases
[3] San Giovanni Hospital, Department of Clinical and Biological Sciences
[4] University of Bern,Department of Dermatology
[5] Inselspital,Dermatologic Clinic, Faculty of Medicine
[6] University of Strasbourg,undefined
来源
Clinical Reviews in Allergy & Immunology | 2017年 / 53卷
关键词
Cutaneous lupus erythematosus; Dermal lupus erythematosus; Discoid lupus erythematosus; Systemic lupus erythematosus;
D O I
暂无
中图分类号
学科分类号
摘要
Systemic lupus erythematosus is a complex autoimmune disease with a wide spectrum of clinical and immunopathological features. Cutaneous and articular manifestations are the most common signs in patients with systemic lupus erythematosus. We here review the pathogenesis and the new classification of cutaneous lupus erythemathosus with a discussion of the significance of the various cutaneous signs. The lesions are classified according to the level of the cellular infiltrate and tissue damage in the epidermis, dermis, and/or subcutis. Furthermore, cutaneous lesions pointing to the presence of a thrombotic vasculopathy and those due to a distinct inflammatory, neutrophilic-mediated reaction pattern are highlighted. Particular attention will be given in describing the histology of skin manifestation. Treatment options for cutaneous lupus erythemathosus have increased with the introduction of new biological therapies. However, the majority of the patients still benefit from antimalarials, which remain the cornerstone of treatment. The evaluation and management of cutaneous lupus erythemathosus patients depend on the clinical findings and associated symptoms.
引用
收藏
页码:291 / 305
页数:14
相关论文
共 440 条
[1]  
Obermoser G(2010)Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates Lupus 19 1050-1070
[2]  
Sontheimer RD(2006)Lupus erythematosus: systemic and cutaneous manifestations Clin Dermatol 24 348-362
[3]  
Zelger B(2011)Cutaneous lupus erythematosus: update of therapeutic options part I J Am Acad Dermatol 65 179-193
[4]  
Rothfield N(2009)Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study Arch Dermatol 145 249-253
[5]  
Sontheimer RD(2011)Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden Br J Dermatol 164 1335-1341
[6]  
Bernstein M(2015)Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States Arthritis Care Res (Hoboken) 67 817-828
[7]  
Kuhn A(2012)Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus Arthritis Rheum 64 2677-2686
[8]  
Ruland V(2000)Lupus erythematosus associated with genetically determined deficiency of the second component of the complement Arch Dermatol 136 1508-1514
[9]  
Bonsmann G(2012)Taming lupus-a new understanding of pathogenesis is leading to clinical advances Nat Med 18 871-882
[10]  
Durosaro O(2010)Genetic susceptibility to systemic lupus erythematosus in the genomic era Nat Rev Rheumatol 6 683-692